Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils
Louise W. Treffers, Michel van Houdt, Christine W. Bruggeman, et al.
Frontiers in Immunology (2019) Vol. 9
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

Tumor-associated neutrophils and neutrophil-targeted cancer therapies
Haiying Que, Qianmei Fu, Tianxia Lan, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188762-188762
Open Access | Times Cited: 150
Expression, Role, and Regulation of Neutrophil Fcγ Receptors
Yu Wang, Friederike Jönsson
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 148
Trastuzumab Mechanism of Action; 20 Years of Research to Unravel a Dilemma
Hamid Maadi, Mohammad Hasan Soheilifar, Wonshik Choi, et al.
Cancers (2021) Vol. 13, Iss. 14, pp. 3540-3540
Open Access | Times Cited: 114
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Antonino Musolino, William J. Gradishar, Hope S. Rugo, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003171-e003171
Open Access | Times Cited: 90
The Ligands for Human IgG and Their Effector Functions
Steven W. de Taeye, Theo Rispens, Gestur Vidarsson
Antibodies (2019) Vol. 8, Iss. 2, pp. 30-30
Open Access | Times Cited: 133
Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG
Arianne M. Brandsma, Sina Bondza, Mitchell Evers, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 115
Resistance to Trastuzumab
Sneha Vivekanandhan, Keith L. Knutson
Cancers (2022) Vol. 14, Iss. 20, pp. 5115-5115
Open Access | Times Cited: 53
Role of Fc Core Fucosylation in the Effector Function of IgG1 Antibodies
Josée Golay, Alain E. Andrea, Irene Cattaneo
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 50
Improving Antibody Therapeutics by Manipulating the Fc Domain: Immunological and Structural Considerations
George Delidakis, Jin Eyun Kim, Katia George, et al.
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 249-274
Open Access | Times Cited: 47
Reimagining antibody-dependent cellular cytotoxicity in cancer: the potential of natural killer cell engagers
Sheena Pinto, Jens Pahl, Arndt Schottelius, et al.
Trends in Immunology (2022) Vol. 43, Iss. 11, pp. 932-946
Open Access | Times Cited: 47
Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy
Shahryar Khoshtinat Nikkhoi, Geng Li, Suha Eleya, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 28
Fcγ receptors and immunomodulatory antibodies in cancer
Felipe Gálvez‐Cancino, Alexander P. Simpson, Cristóbal Costoya, et al.
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 51-71
Closed Access | Times Cited: 21
Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine
Sietse Q. Nagelkerke, David E. Schmidt, Masja de Haas, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 73
Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function
Andrew R. Crowley, Margaret E. Ackerman
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 61
Harnessing the immune system via FcγR function in immune therapy: a pathway to next‐gen mAbs
Alicia M. Chenoweth, Bruce D. Wines, Jessica C. Anania, et al.
Immunology and Cell Biology (2020) Vol. 98, Iss. 4, pp. 287-304
Open Access | Times Cited: 55
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
Kristina Ellwanger, Uwe Reusch, Ivica Fucek, et al.
mAbs (2019) Vol. 11, Iss. 5, pp. 899-918
Open Access | Times Cited: 54
Fc Engineering Strategies to Advance IgA Antibodies as Therapeutic Agents
Geert van Tetering, Mitchell Evers, Chilam Chan, et al.
Antibodies (2020) Vol. 9, Iss. 4, pp. 70-70
Open Access | Times Cited: 53
Antibody glycosylation: impact on antibody drug characteristics and quality control
Ziyan Wang, Jianwei Zhu, Huili Lu
Applied Microbiology and Biotechnology (2020) Vol. 104, Iss. 5, pp. 1905-1914
Closed Access | Times Cited: 50
Afucosylated IgG responses in humans – structural clues to the regulation of humoral immunity
Janita J. Oosterhoff, Mads Delbo Larsen, C. Ellen van der Schoot, et al.
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 800-814
Open Access | Times Cited: 33
Neutrophils as immune effector cells in antibody therapy in cancer
Leonie M. Behrens, Marjolein van Egmond, Timo K. van den Berg
Immunological Reviews (2022) Vol. 314, Iss. 1, pp. 280-301
Open Access | Times Cited: 28
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells
Marta Lustig, Chilam Chan, J.H. Marco Jansen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors
Kerry A. Whalen, Kavya Rakhra, Naveen K. Mehta, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Human tumor-associated macrophages and neutrophils regulate anti-tumor antibody efficacy through lethal and sublethal trogocytosis
Sunil Singhal, Abhishek S. Rao, Jason Stadanlick, et al.
Cancer Research (2024) Vol. 84, Iss. 7, pp. 1029-1047
Open Access | Times Cited: 6
A Comprehensive Review of Fc Gamma Receptors and Their Role in Systemic Lupus Erythematosus
Jesús Sepúlveda-Delgado, Luis Enrique Montiel Llorente, Susana Hernández-Doño
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1851-1851
Open Access
Comparative performance analysis of neoepitope prediction algorithms in head and neck cancer
Leila Y. Chihab, Julie G. Burel, Aaron M. Miller, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Page 1 - Next Page

Scroll to top